...
首页> 外文期刊>Pathology >DNA mismatch repair enzyme immunohistochemistry in colorectal cancer: a comparison of biopsy and resection material.
【24h】

DNA mismatch repair enzyme immunohistochemistry in colorectal cancer: a comparison of biopsy and resection material.

机译:大肠癌中的DNA错配修复酶免疫组化:活检和切除材料的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Microsatellite instability (MSI) in colorectal cancer (CRC) may be predicted using mismatch repair protein (MMRP) immunohistochemistry (immunostaining), allowing focused genetic investigations and potentially influencing therapeutic interventions. Most laboratories perform immunostaining on surgical resection specimens. Endoscopic biopsy specimens are an alternative tissue source for immunostaining. Given the sensitivity of immunostaining to the degree of tissue fixation, endoscopic biopsy material may produce superior staining, based on faster and more thorough fixation. Moreover, in patients receiving neoadjuvant chemotherapy and/or radiotherapy, endoscopic biopsies may be more useful than surgical resection specimens by allowing assessment of MMR status prior to chemotherapy and/or radiotherapy induced changes in tumours. This study examines whether immunostaining for MMRP expression in CRC is as reliable on endoscopic biopsy material as on surgical resection specimens. METHODS: Immunostaining for MLH1, PMS2, MSH2 and MHS6 was performed on 112 unselected CRC cases with both endoscopic biopsy and surgical resection material available. A single observer blindly examined intensity and distribution of staining and assessed MMRP expression. Two consultant histopathologists reviewed challenging cases. Endoscopic biopsies and surgical resections were compared using non-parametric statistical analysis. RESULTS: Immunostaining for all four MMRPs on all 112 cases produced conclusive (i.e., fully interpretable) results in endoscopic biopsies. In surgical resection specimens, 10 stains from nine cases were inconclusive (stains for two MMRPs were inconclusive in one case). In cases where conclusive immunostaining was achieved, there was complete agreement in MMRP status between the endoscopic biopsy and corresponding surgical resection specimens. Overall, MMRP loss was identified in 13% of cases; 11% MLH1, 12% PMS2, 1% MSH2, and 1% MSH6. Immunostaining intensity was significantly higher (p < 0.0005) and the distribution of staining was significantly more uniform (p < 0.0005) on endoscopic biopsy than on surgical resection. CONCLUSION: Endoscopic biopsy provides equal accuracy and easier interpretation of MMRP expression immunostaining compared to surgical resection specimens.
机译:背景:大肠癌(CRC)中的微卫星不稳定性(MSI)可以使用失配修复蛋白(MMRP)免疫组织化学(免疫染色)进行预测,从而可以进行集中的遗传研究并可能影响治疗干预。大多数实验室对手术切除标本进行免疫染色。内窥镜活检标本是免疫染色的替代组织来源。考虑到免疫染色对组织固定程度的敏感性,基于更快更彻底的固定,内窥镜活检材料可产生出色的染色。此外,在接受新辅助化疗和/或放疗的患者中,内镜活检比手术切除标本更有用,因为可以在化疗和/或放疗引起的肿瘤变化之前评估MMR状态。这项研究检查了在内窥镜活检材料上对CRC中MMRP表达进行的免疫染色是否与手术切除标本一样可靠。方法:对112例未选择的CRC病例进行了MLH1,PMS2,MSH2和MHS6的免疫染色,并提供了内窥镜活检和手术切除材料。一位观察者盲目检查了染色的强度和分布并评估了MMRP表达。两名顾问组织病理学家审查了具有挑战性的病例。使用非参数统计分析比较内窥镜活检和手术切除。结果:对所有112例病例的所有四个MMRP进行的免疫染色均得出结论性(即完全可解释),导致内镜活检。在手术切除标本中,来自9例的10个染色是不确定的(其中2个MMRP的染色是不确定的)。如果实现了最终免疫染色,则内窥镜活检和相应的手术切除标本之间的MMRP状态完全一致。总体而言,在13%的案例中发现了MMRP丢失; 11%MLH1、12%PMS2、1%MSH2和1%MSH6。与手术切除相比,内窥镜活检的免疫染色强度显着更高(p <0.0005),染色分布更均匀(p <0.0005)。结论:与手术切除标本相比,内窥镜活检可提供相同的准确性,并且更容易解释MMRP表达的免疫染色。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号